Tricyclic Pyrazoles. Part 5. Novel 1,4-Dihydroindeno[1,2-c]pyrazole CB2 Ligands Using Molecular Hybridization Based on Scaffold Hopping.

Q2 Pharmacology, Toxicology and Pharmaceutics

Open Medicinal Chemistry Journal Pub Date : 2012-01-01 Epub Date: 2012-05-17 DOI:10.2174/1874104501206010001

Gabriele Murineddu, Battistina Asproni, Stefania Ruiu, Francesco Deligia, Matteo Falzoi, Amedeo Pau, Brian F Thomas, Yanan Zhang, Gérard A Pinna, Luca Pani, Paolo Lazzari

{"title":"Tricyclic Pyrazoles. Part 5. Novel 1,4-Dihydroindeno[1,2-c]pyrazole CB2 Ligands Using Molecular Hybridization Based on Scaffold Hopping.","authors":"Gabriele Murineddu, Battistina Asproni, Stefania Ruiu, Francesco Deligia, Matteo Falzoi, Amedeo Pau, Brian F Thomas, Yanan Zhang, Gérard A Pinna, Luca Pani, Paolo Lazzari","doi":"10.2174/1874104501206010001","DOIUrl":null,"url":null,"abstract":"<p><p>In search of new selective CB2 ligands, the synthesis and preliminary biological evaluation of novel 1,4-dihydroindeno[1,2-c]pyrazole hybrids of the highly potent prototypicals 5-(4-chloro-3-methylphenyl)-1-(4-methylbenzyl)-N-fenchyl-1H-pyrazole-3-carboxamide 1 and 1-(2,4-dichlorophenyl)-6-methyl-N-(piperidin-1-yl)-1,4-dihydroindeno[1,2-c]pyrazole-3-carboxamide 2 are detailed.We postulated that the introduction of those pharmacophoric elements essential for activity of 1 in the tricyclic core of 2 might provide CB2 ligands with further improved receptor selectivity and biological activity. Among the compounds, 6-chloro-7-methyl-1-(2,4-dichlorophenyl)-N-fenchyl-1,4-dihydroindeno[1,2-c]pyrazole-3-carboxamide (22) exhibited low two digit nanomolar affinity for the cannabinoid CB2R and maintained a high level of CB2-selectivity.</p>","PeriodicalId":39133,"journal":{"name":"Open Medicinal Chemistry Journal","volume":"6 ","pages":"1-14"},"PeriodicalIF":0.0000,"publicationDate":"2012-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.2174/1874104501206010001","citationCount":"12","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Open Medicinal Chemistry Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/1874104501206010001","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2012/5/17 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}

引用次数: 12

Abstract

In search of new selective CB2 ligands, the synthesis and preliminary biological evaluation of novel 1,4-dihydroindeno[1,2-c]pyrazole hybrids of the highly potent prototypicals 5-(4-chloro-3-methylphenyl)-1-(4-methylbenzyl)-N-fenchyl-1H-pyrazole-3-carboxamide 1 and 1-(2,4-dichlorophenyl)-6-methyl-N-(piperidin-1-yl)-1,4-dihydroindeno[1,2-c]pyrazole-3-carboxamide 2 are detailed.We postulated that the introduction of those pharmacophoric elements essential for activity of 1 in the tricyclic core of 2 might provide CB2 ligands with further improved receptor selectivity and biological activity. Among the compounds, 6-chloro-7-methyl-1-(2,4-dichlorophenyl)-N-fenchyl-1,4-dihydroindeno[1,2-c]pyrazole-3-carboxamide (22) exhibited low two digit nanomolar affinity for the cannabinoid CB2R and maintained a high level of CB2-selectivity.

Abstract Image

查看原文本刊更多论文

三环摘要。第5部分。新型1,4-二氢茚[1,2-c]吡唑CB2配体的分子杂交研究。

为了寻找新的选择性CB2配体，详细介绍了高效原型5-(4-氯-3-甲基苯基)-1-(4-甲基苄基)- n-芬基- 1h -吡唑-3-羧基酰胺1和1-(2,4-二氯苯基)-6-甲基- n-(胡椒碱-1-基)-1,4-二氢茚- [1,2-c]吡唑-3-羧基酰胺2的新型1,4-二氢茚[1,2-c]吡唑复合物的合成和初步生物学评价。我们推测，在2的三环核心中引入1活性所必需的药效元件可能会进一步提高CB2配体的受体选择性和生物活性。在这些化合物中，6-氯-7-甲基-1-(2,4-二氯苯基)- n -芬基-1,4-二氢茚[1,2-c]吡唑-3-羧酰胺(22)对大麻素CB2R具有低两位数纳米摩尔亲和力，并保持高水平的cb2选择性。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Open Medicinal Chemistry Journal Pharmacology, Toxicology and Pharmaceutics-Pharmaceutical Science

CiteScore

4.40

自引率

0.00%

发文量